Evidence map›Paper›PMID 34816014›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Lifestyle- and comorbidity-related factors for the prescription of proton pump inhibitors after

Furitsu Shimada, Hiroyoshi Endo, Ayako Takamori, Takuya Matsunaga, Shun Fujimoto, Shimpei Shirai, Toshihiko Kakiuchi, Takashi Akutagawa, Yasuhisa Sakata, Koichi Node and 4 more

Abstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Furitsu ShimadaDivision of Gastroenterology Saiseikai Karatsu Hospital Saga Japan.ORCID https://orcid.org/0000-0002-2976-4456
Hiroyoshi EndoDivision of Gastroenterology Saiseikai Karatsu Hospital Saga Japan.
Ayako TakamoriDivision of Clinical Research Center Saga University Hospital Saga Japan.
Takuya MatsunagaDivision of Gastroenterology Saiseikai Karatsu Hospital Saga Japan.
Shun FujimotoDivision of Gastroenterology Saiseikai Karatsu Hospital Saga Japan.
Shimpei ShiraiDivision of Gastroenterology Saiseikai Karatsu Hospital Saga Japan.
Toshihiko KakiuchiDepartment of Pediatrics, Faculty of Medicine Saga University Saga Japan.
Takashi AkutagawaDepartment of Internal Medicine, Faculty of Medicine Saga University Saga Japan.
Yasuhisa SakataDepartment of Internal Medicine, Faculty of Medicine Saga University Saga Japan.
Koichi NodeDepartment of Internal Medicine, Faculty of Medicine Saga University Saga Japan.
Kohei YamanouchiInternational University of Health and Welfare Fukuoka Japan.
Shotaro NakamuraInternational University of Health and Welfare Fukuoka Japan.
Kazuma FujimotoInternational University of Health and Welfare Fukuoka Japan.
Motohiro EsakiDepartment of Internal Medicine, Faculty of Medicine Saga University Saga Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimThe aim of the present study was to examine the lifestyle- and comorbidity-related determinant factors of the prescription of proton pump inhibitors (PPIs) for patients in whom

methodsThis retrospective study included patients who underwent

resultsPPIs were administered to 124 of 389 patients (31.9%). The only lifestyle-related risk factor for the prescription of PPIs after

conclusionThe lifestyle- and comorbidity-related risk factors for the prescription of PPIs after

Indexed as

agingclinical symptomshypertensionpotassium‐competitive acid blockerreflux esophagitis

Identifiers

PMID34816014
PMCPMC8593788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.